Clover Health Investments (NASDAQ:CLOV) & Omnicell (NASDAQ:OMCL) Head-To-Head Review

Clover Health Investments (NASDAQ:CLOV) and Omnicell (NASDAQ:OMCL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings.

Risk & Volatility

Clover Health Investments has a beta of 1.86, suggesting that its stock price is 86% more volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Clover Health Investments and Omnicell, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	0	1	2	0	2.67
Omnicell	0	3	4	0	2.57

Clover Health Investments presently has a consensus price target of $4.83, suggesting a potential upside of 62.19%. Omnicell has a consensus price target of $44.83, suggesting a potential upside of 64.59%. Given Omnicell’s higher possible upside, analysts plainly believe Omnicell is more favorable than Clover Health Investments.

Insider & Institutional Ownership

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 97.7% of Omnicell shares are held by institutional investors. 24.1% of Clover Health Investments shares are held by company insiders. Comparatively, 2.5% of Omnicell shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Clover Health Investments and Omnicell”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$1.37 billion	1.11	-$43.01 million	($0.05)	-59.60
Omnicell	$1.11 billion	1.15	$12.53 million	$0.46	59.22

Omnicell has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Clover Health Investments and Omnicell’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-1.69%	-7.42%	-4.00%
Omnicell	1.87%	4.60%	2.56%

Summary

Omnicell beats Clover Health Investments on 10 of the 14 factors compared between the two stocks.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

About Omnicell

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.